POSSIBILITIES AND PROBLEMS OF HEPATOPROTECTORS APPLICATION IN PATIENTS WITH CHRONIC HEPATITIC C AND CONCOMITAMT AUTOIMMUNE SYNDROME
A study of clinical and biochemical parameters of hepatoprotectors efficiency in 32 patients with chronic hepatitis С without signs of cirrhosis and with concomitant autoimmune component has been carried out. A significant difference hasbeen determined between therapeutic impact of bioflavonoid hepatoprotectors and hepatoprotectors with ornithine on indices of liver and immune system function, as well as on hepati­tis course.